Zhi Hong Chen
Director/Board Member chez Shanghai Neutan Pharmaceutical Co., Ltd.
Profil
Zhi Hong Chen is currently a Director at Shanghai Neutan Pharmaceutical Co., Ltd.
Previously, he worked as the General Manager & Director at Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Postes actifs de Zhi Hong Chen
| Sociétés | Poste | Début |
|---|---|---|
Shanghai Neutan Pharmaceutical Co., Ltd.
 Shanghai Neutan Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Neutan Pharmaceutical Co., Ltd. provides synthetic chemistry and customization services. Shanghai Neutan Pharmaceutical Co. is a national high-tech enterprise and a one-stop full-process innovative drug CDMO platform. The company is based in Shanghai, China. The Chinese company has established a complete quality assurance system that complies with domestic and international GMP standards. The company offers high-quality CMC, clinical samples, and commercial products. The company's business scope includes pre-clinical CRO, new drug discovery FTE, CMC, new drug discovery FFS, CXO, etc. The company was founded in 2019 by Xue Jun Liu, and the CEO is Xiao Dong Chen. | Director/Board Member | - |
Anciens postes connus de Zhi Hong Chen
| Sociétés | Poste | Fin |
|---|---|---|
| ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD | Chief Executive Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shanghai Neutan Pharmaceutical Co., Ltd.
Shanghai Neutan Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Neutan Pharmaceutical Co., Ltd. provides synthetic chemistry and customization services. Shanghai Neutan Pharmaceutical Co. is a national high-tech enterprise and a one-stop full-process innovative drug CDMO platform. The company is based in Shanghai, China. The Chinese company has established a complete quality assurance system that complies with domestic and international GMP standards. The company offers high-quality CMC, clinical samples, and commercial products. The company's business scope includes pre-clinical CRO, new drug discovery FTE, CMC, new drug discovery FFS, CXO, etc. The company was founded in 2019 by Xue Jun Liu, and the CEO is Xiao Dong Chen. | Health Technology |
